Join experts Andreas Reiter, a professor specializing in myeloid lympho-neoplasms, Claire Harrison, who co-authored key research on treating low-risk polycythemia vera, and Aaron Gerds, a doctor focusing on anemia in myelofibrosis. They discuss groundbreaking advances in treating myeloproliferative neoplasms, highlighting the importance of personalized medicine. Learn about evolving strategies for managing polycythemia vera, the complexities of anemia treatment, and the significance of thorough testing for rare conditions. Their insights pave the way for enhanced patient care.
